Statistics

Total Visits

Views
Bosutinib apears to be safe, with low cross intolerance, in patients treated in 4th line. Results of the Spanish compassionate use program69

Select a period of time:

Number of views in the range

Views
Bosutinib apears to be safe, with low cross intolerance, in patients treated in 4th line. Results of the Spanish compassionate use program23

Views

Views
November 20252
December 20251
January 20263
February 20261
March 20266
April 20261
May 20269
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States11
United Kingdom3
Argentina1
Brazil1
Colombia1
Dominican Republic1
Ecuador1
Spain1
Finland1
Mauritius1
 

Top cities views

Views
Los Angeles2
Bogotá1
Buenos Aires1
Canoinhas1
Douglas1
Helsinki1
Madrid1
Miami1
San Jose1
Santa Clara1